Showing results (151-160 of 155) with videos related to
Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 155 results.
Cancer|December 24, 1997
A pilot pharmacokinetic and immunoscintigraphic study with the technetium-99m-labeled monoclonal antibody BC-1 directed against oncofetal fibronectin in patients with brain tumorsG Mariani, A Lasku, A Pau, et al.Cancer Research|April 1, 1988
Antibody guided targeting of non-small cell lung cancer using 111In-labeled HMFG1 F(ab')2 fragmentsH P Kalofonos, G B Sivolapenko, N S Courtenay-Luck, et al.International Journal of Colorectal Disease|May 3, 2005
Immune responses in advanced colorectal cancer following repeated intradermal vaccination with the anti-CEA murine monoclonal antibody, PR1A3: results of a phase I studyA P Zbar, H Thomas, R W Wilkinson, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2006
Phase III trial of intraperitoneal therapy with yttrium-90-labeled HMFG1 murine monoclonal antibody in patients with epithelial ovarian cancer after a surgically defined complete remissionRené H Verheijen, Leon F Massuger, Benedict B Benigno, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 1998
CAMPATH-1H monoclonal antibody in therapy for previously treated low-grade non-Hodgkin's lymphomas: a phase II multicenter study. European Study Group of CAMPATH-1H Treatment in Low-Grade Non-Hodgkin's LymphomaJ Lundin, A Osterborg, G Brittinger, et al.Pageof 16